The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

Journal: Nature Medicine

Published: 2018-08-27

DOI: 10.1038/s41591-018-0156-x

Affiliations: 40

Authors: 54

Go to article
Institutions FC
Research Center for Molecular Medicine (CeMM), ÖAW, Austria 0.13
Central Nervous System Tumor Unit (CCC-CNS), MUW, Austria 0.12
Department of Neurology and Neurosurgery, MUI, Austria 0.08
University Hospital of St. Poelten, KL, Austria 0.06
Klinikum Klagenfurt am Wörthersee, Austria 0.06
Christian-Doppler-Klinik, PMU, Austria 0.06
Institute of Neurology (CIN), MUW, Austria 0.05
Rudolfstiftung Hospital, Austria 0.04
Department of Neurosurgery, Med Uni Graz, Austria 0.04
Department of Neurosurgery, MUW, Austria 0.04
Kepler Universitätsklinikum GmbH, Austria 0.04
Johannes Kepler University of Linz (JKU), Austria 0.04
Center for Medical Physics and Biomedical Engineering (MPBT), MUW, Austria 0.04
Computational Imaging Research Laboratory (CIR), MUW, Austria 0.04
Department of Pathology, MUI, Austria 0.02
Medical University of Graz (Med Uni Graz), Austria 0.02
Department of Radiology, MUI, Austria 0.02
Department of Neurology, Med Uni Graz, Austria 0.02
Center for Public Health Genomics (CPHG), UVA, United States of America (USA) 0.02
Landesklinikum Wiener Neustadt, LKNOE, Austria 0.02
Department of Medicine I, MUW, Austria 0.02
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.01
Klinische Abteilung für Neuroradiologie und Muskuloskeletale Radiologie, MUW, Austria 0.01
Department of Radiotherapy, MUW, Austria 0.01
Faculty of Medicine (MED), OVGU, Germany 0.01
Department of Laboratory Medicine, MUW, Austria 0
Max Planck Institute for Informatics (MPI-INF), Germany 0
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Austria 0

Return